Top Picks Comparison Table
| Provider | Best For | Starting Price | Patient-First Score | Apply Now |
|---|---|---|---|---|
| Trimi Health | Cheapest Legitimate $99 Semaglutide in 2026 | $99/mo | — | See Offer |
| Eden | Best Async Support Network Despite First-Month Bait | $100/mo | 87 / 100 | See Offer |
| Embody | Best Flat-Rate Pricing With a Twelve-Month Price Lock | $149/mo | — | — |
| IVYRx | The Only Real 503B Option Under $200 | $175/mo | 80 / 100 | See Offer |
| Peak Wellness | Best Flat-Rate Through Maintenance, Higher Sticker Than Trimi or Eden | $129/mo | 77 / 100 | See Offer |
| MedVi | Cheap Entry Price, Expensive Reality After Month One | $179/mo | 88 / 100 | See Offer |
| Henry Meds | Established Brand, Aggressive Dose-Tier Tax | $179/mo | 96 / 100 | See Offer |
| Mochi Health | Why $99 Becomes $178 and Why We Cannot Recommend It in 2026 | $99/mo | 90 / 100 | See Offer |
Trimi advertises $99/month all-inclusive semaglutide and the math actually holds. Mochi advertises $99/month semaglutide and the real number is $178 once a mandatory $79.99 membership lands on your card. Same headline, wildly different invoices.
Type “cheapest GLP-1 compounding pharmacy” into Google in May 2026 and you get back $79 microdoses that top out at a quarter of a maintenance dose, $92 anchor prices that disappear at refill, and platforms that name no pharmacy on their site at all. Compounded GLP-1 still saves the average cash-pay patient $900 to $1,100 a month versus brand-name Wegovy or Zepbound. Only if the cheap option is actually cheap and actually safe.
Two FDA moves reshaped this market in the last sixty days. On April 1, 2026, the FDA clarified that 503A compounders can only fill four prescriptions per month of the same compounded GLP-1 before tripping the “essentially a copy” rule. On April 30, 2026, the FDA proposed permanently removing semaglutide, tirzepatide, and liraglutide from the 503B bulks list. The public comment period closes June 29, 2026. Read this as a May 2026 snapshot of who is still standing and what each one is actually charging.
Methodology first, then 503A versus 503B in plain English, then eight providers ranked by total program value with the pharmacy named wherever the platform discloses it. The FAQ resolves the ReflexMD $92 question and the IvyRx $175 question. Eight providers ranked. Pharmacies named. Hidden costs surfaced.
How We Ranked the Cheapest Compounded GLP-1 Providers (Plus 503A vs 503B in Plain English)
Cheap that strands you in month four is not cheap. And the pharmacy filling your script matters more than the platform you signed up with, because the platform is the marketing layer on top of the compounding facility doing the work.
Our Ranking Criteria
Six criteria, applied evenly to every provider on this list and every provider you find on your own:
- Total annual cost, not month-one bait price. Project 12 to 18 months of medication, including dose-tier escalation, and rank on the total. A $99 start that turns into $249 by month four costs more over a year than a $149 flat-rate.
- Named compounding pharmacy partner. A platform that names its 503A or 503B pharmacy is taking accountability. A platform that hides it is renting reputation without sharing risk.
- 503A or 503B clarity. Patients who do not know which tier fills their vial are flying blind on the biggest quality variable.
- Flat-rate versus dose-tier escalation. Henry, MEDVi, GobyMeds, and ShedRx raise the price as you titrate. Trimi, Eden, Embody, IvyRx, and Peak Wellness hold it flat. Twelve months in, this swings $1,000.
- Patient-experience signals during titration. Messaging response time, dose-pause policy when nausea spikes, anti-emetic inclusion. Trimi and Direct Meds include Zofran. Most do not.
- Cancellation and continuity policy. Cancel-anytime means nothing if the button is missing from the portal. We flag providers whose cancellation requires email, whose prepays are non-refundable, or whose pharmacy has shut down without warning.
One disclosure. Peak Wellness owns this publication. Peak ranks at #5 on this list because Trimi ($99) and Eden ($100) win on entry sticker, IvyRx is the only sub-$200 503B option, and Embody locks twelve months at $149. We applied the same six criteria to Peak as to every other provider on the list, and we explain Peak’s case in its section below. If you run the criteria yourself and land somewhere else, the math in each section will tell you why.
A 60-second pressure test on any provider not on this list: ask which pharmacy fills the script, look it up on the NABP VIPPS database at nabp.pharmacy, search the state board of pharmacy by name, and check LegitScript for the telehealth platform. If any returns nothing, walk.
503A vs 503B and the April 2026 FDA Shift
Bottom line in two sentences. 503A pharmacies fill one prescription for one patient under state board supervision. 503B outsourcing facilities batch-manufacture under direct FDA inspection and cGMP standards.
503A compounders work prescription-by-prescription. Under the April 1, 2026 FDA clarification, a 503A pharmacy can fill no more than four scripts per month of the same compounded GLP-1 before regulators consider it “essentially a copy” of brand-name semaglutide or tirzepatide. The prescription must document why the patient needs the compound rather than the FDA-approved drug. “Patient preference and cost savings alone are insufficient justifications,” in FDA’s words. Most cheap telehealth platforms run on 503A pharmacies: Empower, Belmar, Hallandale, Strive, Epiq Scripts, Casa Pharma Rx, and Tailor Made.
503B outsourcing facilities operate at a higher regulatory tier. They are FDA-inspected, subject to current Good Manufacturing Practice, and can produce stock for office use. The April 30, 2026 FDA proposal would permanently remove semaglutide, tirzepatide, and liraglutide from the 503B bulks list, citing “no clinical need” given FDA-approved versions exist. Comment period closes June 29, 2026. If finalized in late 2026, 503B compounded GLP-1 becomes harder to source legally. IvyRx markets a 503B pipeline through Olympia Pharmaceuticals. Empower, Olympia, and Belmar run both 503A and 503B operations.
Three questions to run on any provider before paying:
- Which pharmacy fills my script?
- Is that pharmacy 503A or 503B?
- Is it PCAB-accredited or NABP VIPPS-verified?
We will re-audit this page after the June 29 comment period closes.
1. Trimi Health: Cheapest Legitimate $99 Semaglutide in 2026
If $99 semaglutide is real, this is the version that is real. Trimi names its pharmacies, includes nausea support, and runs through a 50-state clinician network. The catch is async-only support.
Pricing. Semaglutide $99/month, tirzepatide $125/month, all-inclusive. That price covers medication, asynchronous clinician messaging, regular check-ins, free shipping, and Zofran for nausea. No long-term contract.
Pharmacy partner. VialsRx, Texas State Board of Pharmacy license #35264, and GreenwichRx. Public disclosure of state licenses in the marketing copy is rare in this category, and Trimi does it. Worth weighting.
503A vs 503B status. 503A.
What is included. Medication, async clinician messaging through Beluga Health’s 50-state network, free shipping (5 to 7 business days, slower than Peak Wellness or IvyRx), and the Zofran anti-nausea inclusion that separates Trimi from nearly every cheap-tier competitor.
Dose-tier policy. Flat. The $99 holds through titration to maintenance dose. This is what distinguishes Trimi from the $99-becomes-$249 bait providers covered later.
Patient-experience signal. 4.7/5 on Facebook across 192+ reviews and 4.6/5 on Trustpilot across 48 reviews. Patients report that async-only consultations feel limiting during the side-effect peak in weeks three through six. One patient quote on Trimi’s own community page: “Process was kind of confusing and only messaging a doctor was a little disheartening, I love the comfort of a video visit.” Take it seriously if you anticipate needing real-time clinical support during titration.
Bottom line. Trimi is our #1 pick for cheapest legitimate compounded GLP-1 in 2026. The $99 holds through every dose, the pharmacies are named, and the Zofran inclusion is uncommon at this price tier. If you want synchronous video care or a 48-hour shipping window, Eden (#2) and Peak Wellness (#5) are the closest upgrades.
2. Eden Health: Best Async Support Network Despite First-Month Bait
Eden has 127,000+ patients and 24/7 human messaging. It also has first-month bait pricing that jumps $100 at month two. If support during titration is your top concern, Eden earns the slot even at $249 ongoing.
Pricing. Compounded semaglutide $149 the first month, then $249/month ongoing. Compounded tirzepatide $249 the first month, then $329/month ongoing. After month two, the same-price-at-every-dose pledge kicks in.
The bait is the issue and deserves a direct callout. Eden advertises $149 starting. That is one month. Plan your budget against $249 from month two forward, because that is the price you will actually pay if you stay on for a clinically meaningful run.
Pharmacy partner. Not publicly disclosed. Eden describes its supply chain as an “exclusive pharmacy network” with third-party batch testing from FDA-registered labs. The non-disclosure is a downgrade signal that balances against the operational scale of the platform.
503A vs 503B status. 503A network.
What is included. Medication, 24/7 messaging with a US-based human care team (not bots, per the platform’s marketing and confirmed by multiple independent reviews), and free shipping. The support is the standout.
Dose-tier policy. Flat after the first-month bait. Eden does not raise the price when you titrate up from 0.25mg to 2.4mg semaglutide maintenance, which is genuinely useful at a $249 monthly run-rate.
Patient-experience signal. Trustpilot 4.3/5 across roughly 3,000 reviews, the strongest review volume in this ranking. Self-reported average loss of 29 lbs over 6 months in a 111-user sample published by the platform. Reddit threads flag dosing errors and auto-renewal surprises on a recurring basis. Turn off auto-renewal on the first dose.
Bottom line. Eden is the right choice if support during weeks three through six of titration is what you are optimizing for. Budget for $249 from month two and disable auto-renewal the day your first shipment lands.
3. Embody: Best Flat-Rate Pricing With a Twelve-Month Price Lock
Embody locks $149/month at every dose from month one through month twelve. No tier jumps, no escalation tax, no first-month bait. The certainty is the product.
Pricing. $149/month flat across all doses for both compounded semaglutide and compounded tirzepatide on the Flat Program. The pledge is the headline: same rate at every dose for 12 months regardless of escalation. A GLP-1 gum format runs $199/month if you prefer non-injectable.
Pharmacy partner. Not publicly disclosed. Embody states it works with state-licensed 503A compounding pharmacies, LegitScript-verified. The non-disclosure is a downgrade signal that holds the brand back from a higher ranking despite the pricing structure.
503A vs 503B status. 503A.
What is included. Consultation, medication, supplies, unlimited 24/7 messaging with the care team, and 1 to 2 day free shipping. A 100% satisfaction guarantee tied to adherence and outcomes.
Dose-tier policy. Flat. This is the entire pitch. Here is what flat actually buys you. A Henry-style escalation from $247 at 2.5mg semaglutide to $347 at 7.5mg over a 12-month protocol costs an extra $1,200 on top of base. Embody locks that line at $1,788 for the full year. The math is the moat.
Patient-experience signal. 350,000+ patients per company disclosure. Trustpilot volume is thinner than Eden’s, and the brand is younger than Henry or Mochi, which means the public review signal is still settling. Smaller, newer brands also carry more shutdown risk; the Zappy and Ousia shutdown in January 2025 stranded thousands of prepaid patients without recourse.
Pros. The only true 12-month price-lock in the cheap tier with the math published transparently. Cons. Pharmacy partner not disclosed, and the smaller patient base means thinner safety and continuity signal than Eden or Henry.
4. IvyRx: The Only Real 503B Option Under $200
IvyRx is the answer to the question “what does a 503B compounded GLP-1 cost?” $175 to $197 a month for semaglutide, $275 to $297 for tirzepatide, no dose-tier escalation. The premium buys you cGMP and FDA inspection at the pharmacy level.
The $175 number you have seen across three different review sites is monthly, not weekly. It is semaglutide at the starting maintenance range. Tirzepatide starts at $275. Both prices hold flat through dose escalation. That settles a question competitor articles have been dancing around for six months.
Pricing. Compounded semaglutide $175 to $197/month. Compounded tirzepatide $275 to $297/month. No membership fee. No first-month bait.
Pharmacy partner. Olympia Pharmaceuticals, the 503B outsourcing facility (not to be confused with the 503A Olympia Pharmacy retail operation; the same parent runs both). Olympia is one of the few pharmacies operating at both regulatory tiers, and IvyRx is one of the few telehealth platforms that publicly markets its 503B pipeline.
503A vs 503B status. 503B. This is the moat for this provider and the reason it earns the #4 slot over cheaper 503A platforms.
What is included. Medication, medical evaluation, ongoing support, and shipping. All-inclusive monthly charge.
Dose-tier policy. Flat across dose escalation.
Patient-experience signal. Smaller patient base than Eden or Henry; independent review volume is modest. Independent FDA-registered lab verification of each batch is published, which is uncommon in this tier.
Best for. Patients who specifically want a 503B compounder for the cGMP and FDA-inspection upgrade, and who can budget $175 to $275/month for that regulatory tier.
Skip if. $175 to $275/month is outside your budget and you are willing to accept the 503A risk profile at Trimi or Peak Wellness to save the difference.
5. Peak Wellness: Best Flat-Rate Through Maintenance, Higher Sticker Than Trimi or Eden
Peak Wellness holds flat pricing through every dose tier, which is the moat. The sticker sits above Trimi’s $99 and Eden’s $100 entry, which is why it lands at #5 rather than the top of the table. For patients who plan to titrate to maintenance and stay on for twelve months, the flat-rate math closes part of the gap.
Pricing. Semaglutide $129/month with no commitment, $165/month on the 6-month plan ($990 total, includes two free months built in), and $149/month on the 12-month plan. Tirzepatide starts at $229/month. Every tier is flat-rate from 2.5mg through maintenance.
Pharmacy partner. Licensed 503A pharmacies in the Peak Wellness network. The specific pharmacy is not publicly named, which is a downgrade signal we apply consistently across the ranking. Patients can ask the prescribing clinician which pharmacy is filling their script and verify it through NABP.
503A vs 503B status. 503A.
What is included. Physician oversight, syringes, alcohol swabs, free expedited shipping (48 to 72 hour window), portal access, and a dose assistant for each weekly injection.
Dose-tier policy. Flat. The number on your invoice in month one is the number in month twelve. No price jump at 5mg, 7.5mg, 10mg, or maintenance. This is the structural moat and the reason Peak still ranks above Henry and MEDVi despite a higher entry sticker than Trimi or Eden.
Patient-experience signal. A 4-hour physician review claim is the fastest in the ranked list. Trustpilot and BBB profiles are not yet established because the platform is newer than Eden or Henry, so the patient-volume signal is thinner.
Disclosure. Peak Wellness owns this publication. We ranked it #5 because Trimi ($99) and Eden ($100) beat it on entry sticker, IvyRx is the only 503B option under $200, and Embody locks twelve months at $149. The same six methodology criteria were applied to Peak as to every other provider on this list. Disclosure first, then the math.
Best for. Self-directed adults willing to pay $30/month more than Trimi to lock flat pricing through maintenance, get expedited shipping, and use a structured patient portal.
Skip if. You need scheduled video consultations, want a named pharmacy listed on the marketing page, or are happy to save $30/month at Trimi and accept async-only support.
6. MEDVi: Cheap Entry Price, Expensive Reality After Month One
MEDVi advertises $179. The real number is $299 for the injection and $349 for the oral tablet from month two forward. Cancellation requires emailing support; there is no in-portal button. Read the section before you enter a credit card.
Pricing. Compounded semaglutide injection $179 first month, then $299/month ongoing. Oral tablet $249 first month, then $369/month ongoing. Tirzepatide injection $279 first month, then $399/month ongoing. The 67% to 95% price jump at refill is the pattern across every SKU.
The pricing delta matters in concrete dollars. A six-month run on the semaglutide injection costs $179 + $299 x 5 = $1,674. Trimi over the same window costs $594. Peak Wellness 6-month plan costs $990. MEDVi runs $680 to $1,080 more for the same active ingredient and a less-disclosed pharmacy footprint.
Pharmacy partner. Link Compound Pharmacy is the single disclosed partner. PCAB accreditation has not been confirmed by independent review. The narrow pharmacy footprint compounds the other transparency issues.
503A vs 503B status. 503A.
What is included. Medication, async consultation, and shipping. Nothing differentiated.
Dose-tier policy. Flat after the first-month bait. The bait pricing matters more than the dose stability.
Patient-experience signal. BBB rating: F. Checkout flow uses countdown timers and artificial urgency. Media endorsement logos (NY Times, Healthline, Fortune) are displayed without linked articles. One independent reviewer documented a vial arriving loose in a ziplock bag, upside-down. Cancellation requires email contact because the in-portal cancel button is absent.
Consider only if the $179 first month is the entire treatment course you can budget for and you plan to cancel by week three. For anyone running a six to twelve month protocol, every provider above this slot costs less per year.
7. Henry Meds: Established Brand, Aggressive Dose-Tier Tax
Henry Meds advertises $179. The real entry price is $297 month-to-month. At month four when you escalate to a therapeutic dose, expect another $100 on the monthly tab. Henry is a real brand with real medication. The pricing pattern is what to read closely.
Pricing. Injectable semaglutide $297/month month-to-month, $247/month on the 6-month prepay, $197/month on the 12-month prepay. Oral semaglutide $249/month. Tirzepatide injectable $449/month. Tirzepatide oral $349/month. Dose escalation adds roughly $100/month per tier above the starting dose.
Pharmacy partner. Hallandale Pharmacy in Florida is one of the named partners, with Health Warehouse as the other. Hallandale is a 503A facility and compounds GLP-1 prescription-by-prescription. The named partner disclosure is the single positive transparency point for Henry.
503A vs 503B status. 503A.
What is included. Medication, consultation, shipping, and provider messaging for dose adjustments. Both oral and injectable options.
Dose-tier policy. Tiered escalation. Walk the math. A 6-month prepay at $247 totals $1,482 base. Add the tier escalation at month four (roughly $100/month for the remaining three months) and you land at about $1,782 over six months. Trimi over six months: $594. Embody: $894. Peak Wellness 6-month plan: $990. Henry costs nearly three times what Trimi costs over the same window for the same active ingredient.
Patient-experience signal. BBB: F rating with 192 complaints over three years. Trustpilot 4.5 across 12,320 reviews, though Trustpilot has flagged the profile for suspected fraudulent reviews. Eli Lilly filed a lawsuit in September 2025 over Henry’s “personalized” tirzepatide marketing. Reddit clusters: auto-renewal billing, cancellation friction, and non-refundable prepays that contradict the “cancel anytime” line.
Why someone still picks Henry. Brand recognition, large patient base, a named pharmacy partner, and oral options.
Why we ranked it #7 anyway. The pricing model is the most opaque among ranked providers, and the gap between advertised and actual is the largest in the list.
8. Mochi Health: Why $99 Becomes $178 and Why We Cannot Recommend It in 2026
Mochi advertises $99 semaglutide. The real monthly cost is $178 after the mandatory $79.99 membership. Their dispensing pharmacy Aequita was raided by Washington State in March 2025 with documented use of day laborers and Alibaba-sourced ingredients. We cannot recommend Mochi in May 2026.
Pricing. $99/month medication plus mandatory $79.99/month membership for portal access, lab reminders, and unlimited text support. True monthly cost: $178. Ads push a $39 starting price, which is the first-month membership discount only.
Pharmacy partner. Aequita Pharmacy in Kirkland, Washington, owned by Mochi Health, is the central evidence. The Washington State Department of Health raid in March 2025 documented illegal ingredient imports from Alibaba, non-pharmacist day laborers handling patient medications, and improper cooling methods during compounding. Whistleblowers drove the investigation. License restrictions followed. Mochi’s portal also lists Seven Cells and Drug Crafters as alternate pharmacy options.
503A vs 503B status. 503A. Aequita’s licensure is currently under regulatory review.
What is included. Medication, membership-gated portal, async consultations, monthly questionnaires, and a video consultation every six months.
Dose-tier policy. Variable. Secondary issue compared to the pharmacy concern.
Patient-experience signal. 15,000+ Trustpilot reviews at 4.4/5, which sits in tension with the documented regulatory record. An active Eli Lilly lawsuit over compounded tirzepatide marketing is also outstanding. One independent reviewer documented medication shipped in a water bottle with thin ice packs.
If you arrived at Mochi looking for $99 semaglutide, the legitimate $99 alternative is Trimi at #2. The legitimate $129 starting alternative is Peak Wellness at #1. Either one will cost less per year and neither comes with a state-investigated dispensing pharmacy.
Cheapest Compounded GLP-1 FAQ: Resolving the Ambiguous Pricing and Continuity Questions
Is the $99 semaglutide from Trimi or CoreAge Rx real or bait pricing?
Yes for Trimi at $99/month all-inclusive with named pharmacy partners (VialsRx, Texas State Board license #35264, and GreenwichRx). CoreAge Rx advertises $99/month for semaglutide and $149/month for tirzepatide on annual billing; verify the billing cycle and refund policy before paying upfront for a full year. Both providers hold the headline price through dose escalation. The platforms where $99 is bait are MEDVi, Henry, and Mochi.
What does ReflexMD’s $92 starting price actually cover?
The $92 is a marketing anchor, not a recurring price. Actual semaglutide pricing at ReflexMD: $249 to $297 the first month, then $497/month ongoing. Tirzepatide runs $347 to $349 the first month, then $547/month ongoing. We do not rank ReflexMD because the price displayed in ads is not the price paid in month two.
What does IvyRx’s $175 cover, weekly or monthly?
Monthly. Semaglutide $175 to $197/month, tirzepatide $275 to $297/month, flat across dose escalation. The confusion in earlier review articles came from sources citing the number without specifying the billing cadence. See section 4 for the full breakdown and the Olympia Pharmaceuticals 503B pipeline.
What hidden costs should I watch for beyond the advertised monthly price?
Five common patterns. First-month bait followed by a 50% to 100% ongoing increase (MEDVi, Henry, Eden). Mandatory membership stacked on medication (Mochi $79.99). Dose-tier escalation that adds $50 to $100 a month at months three to four (Henry, ShedRx, GobyMeds at maintenance). Non-refundable prepays that contradict cancel-anytime marketing (Henry, GobyMeds). State sales tax on compounded medication in some jurisdictions. Always run a 12-month total against the advertised monthly before paying.
Is Noom’s $79 microdose comparable to a $99 full-dose semaglutide?
No. Noom microdose maxes at 0.6mg/week. Full-dose maintenance is 2.4mg/week semaglutide. On a price-per-milligram basis, the $99 full-dose programs at Trimi or CoreAge deliver roughly four to six times the active ingredient per dollar. Noom’s microdose has clinical use cases, but pricing-tier comparisons against full-dose providers are not apples to apples.
What happens if my cheap provider shuts down while I am mid-treatment?
You typically lose unused medication and any prepaid balance. Zappy Health patients who prepaid roughly $1,000 in December 2024 had no recourse when their pharmacy Ousia lost its sterile compounding license in January 2025. Protect against this by paying month-to-month at unknown brands, keeping a 30-day supply on hand before topping up, and saving your prescription details so you can transfer quickly to another telehealth provider. Avoid prepaying more than three months at any brand without an established track record.
Will compounded GLP-1s disappear entirely after 2026?
Not entirely. 503A patient-specific compounding remains legally viable with proper documentation under the April 1, 2026 FDA “essentially a copy” clarification. The April 30, 2026 FDA proposal would remove semaglutide, tirzepatide, and liraglutide from the 503B bulks list; if finalized in late 2026, this narrows 503B access specifically. 503A access continues, subject to the four-prescriptions-per-month-per-pharmacy cap on the same compounded formulation. Public comment closes June 29, 2026.
How do I verify any pharmacy or provider before paying?
Sixty-second checklist. Look up the pharmacy on NABP VIPPS at nabp.pharmacy. Search the state board of pharmacy for the pharmacy by name. Verify LegitScript certification for the telehealth platform. Confirm the prescriber on the NPI registry at npiregistry.cms.hhs.gov. Ask for the batch Certificate of Analysis (HPLC purity above 95%, potency within 10% of label, sterility pass, endotoxin below USP limits). If any of those returns nothing or the provider refuses, walk away.